| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Venrock Healthcare Capital Partners Iii, L.P. is a 10% Owner at KalVista Pharmaceuticals, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 20 buys and 0 sells.
Estimated insider holdings value: $648.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 26,246 | $12.72 | $333,779.23 | +0.3% | -8.5% | -38.7% | |
| Jan 10, 2024 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 137,700 | $12.54 | $1,726,456.92 | +1.1% | -7.1% | -38.2% | |
| Jan 4, 2024 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 59,369 | $12.14 | $720,543.04 | +0.7% | -4.0% | -23.0% | |
| Dec 29, 2023 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 519,017 | $12.46 | $6,465,649.95 | +4.6% | -3.2% | -30.4% | |
| Aug 18, 2020 | COGT Cogent Biosciences, Inc. | 10% Owner | Buy | 451,000 | $2.52 | $1,137,120.00 | +3.7% | - | - | |
| Jun 15, 2020 | ALT Altimmune, Inc. | 10% Owner | Buy | 1,500,000 | $7.54 | $11,310,000.00 | +50.0% | - | - | |
| May 28, 2020 | ALT Altimmune, Inc. | 10% Owner | Buy | 1,303,636 | $8.74 | $11,395,493.13 | +9.2% | - | - |